144Filing Date: Aug 31, 2026

Edwards Lifesciences (EW)

Insider Proposed Sale Notice

View SEC Filing
ACC: 0001921094-26-000970

Sale Plan

Dahl Andrew M.
Officer·Edwards Lifesciences
Proposed
CommonNYSE
Shares544
Est. DateAug 31
Market Value$49.5K
BrokerCharles Schwab & Co., Inc.
AcquisitionRestricted Stock Lapse · EDWARDS LIFESCIENCES CORPORATION
Acquired DateMay 8, 2026
Amount Acquired544
% Outstanding0.0001%
Exercise / Payment Details
Paid: May 8, 2026Method: Equity Compensation
No sales in the past 3 months
Signature & Compliance expand_more
Notice DateAug 31, 2026
Signature Andrew M. Dahl
Issuer Info expand_more
CompanyEdwards Lifesciences Corp
CIK0001099800
SEC File No.001-15525
Phone9492502500
AddressONE EDWARDS WAY, IRVINE, CA 92614

keid analysis is for reference only and does not constitute investment advice.